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ABSTRACT
Background: Zika virus (ZIKV) sexual transmission and prolonged viral shedding in 
semen have been previously reported, suggesting a strong viral affinity for genital tissues. A 
transient impact of ZIKV on male fertility was shown in animal and human studies. Methods: 
Adult male patients with confirmed ZIKV infection diagnosed in the city of Araraquara, 
Brazil during the epidemic season of 2016 were invited one year after the acute infection to 
respond to a questionnaire of genital symptoms and to provide a semen sample for molecular 
ZIKV testing and spermogram analysis, as well as a serum sample for hormonal testing. 
Results: 101 of 187 tested patients had positive ZIKV RT-PCR in plasma and/or urine 
samples (54%, 72 women and 29 men). Of 15 adult male participants for whom telephone 
contact was successful, 14 responded to the questionnaire of genital symptoms and six 
consented to provide a semen sample at a median of 12 months after the acute infection. We 
report abnormal spermogram results from patients one year after confirmed ZIKV infection. 
Conclusions: Our findings suggest a possible long-term detrimental effect of ZIKV infection 
on human male fertility that has to be further explored in well-characterized samples from 
cohort studies conducted in ZIKV-endemic areas.
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BACKGROUND
The Zika virus (ZIKV) infection outbreak in the Americas in the last few 
years was the largest in history, and knowledge on disease transmission routes, 
clinical spectrum and potential complications is still expanding. ZIKV is 
transmitted mainly through the bite of Aedes mosquitos1, but maternal-to-child 
transmission2, transmission through contaminated blood3 and sexual intercourse4 
were also reported. Viral shedding in semen may be prolonged with documented 
shedding lasting up to six months5-7. The virus has been detected in semen from 
a vasectomized man8 and has also been demonstrated in the head of spermatozoa 
by immunohistochemical fluorescence microscopy9, suggesting its affinity for 
different male genital tissues. Worryingly, two previous studies of ZIKV infection 
in mice treated with anti-Ifnar1 blocking monoclonal antibody have demonstrated 
impairment in male fertility, accompanied by testicular atrophy, lower serum 
testosterone and inhibin B levels, as well as oligospermia10,11. A recent study in 
a cohort of 15 ZIKV-infected men showed a transient reduction in sperm counts 
in the acute phase of infection, suggesting a potential impact of ZIKV on human 
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male fertility12. However, ZIKV ability to cause long-term 
impairment on male fertility is unknown. From a cohort of 
101 ZIKV-infected patients from Araraquara, Brazil, we 
assessed hormonal results from six ZIKV-infected men, 
of whom five underwent spermogram analysis in samples 
collected 12 months after the acute infection.
METHODS
Patients with confirmed ZIKV infection diagnosed at a 
single primary care unit during the epidemic season of 2016 
in Araraquara, Sao Paulo State, Brazil, were identified for 
this study. All participants had a positive test by real-time 
reverse transcriptase polymerase chain reaction (RT-PCR) 
in urine and/or plasma samples obtained during the acute 
phase. Adult male patients were invited to respond to a 
short retrospective questionnaire of genital symptoms and 
to provide a semen sample for molecular ZIKV testing 
and spermogram analysis, as well as a serum sample for 
hormonal testing (FSH, LH, testosterone and inhibin B). 
Each participant was instructed to produce and collect the 
semen sample at home by masturbation and to bring the 
sample immediately, in room temperature, to the healthcare 
unit for analysis. The questionnaire of genital symptoms 
included questions on the presence of pain or burning when 
urinating, noticeable blood in semen or urine, testicular 
pain and any genital abnormality at the time of acute ZIKV 
infection or at the time the questionnaire was applied. 
For RT-PCR testing, nucleic acid was extracted from 
a volume of 500 µL of total semen samples using the 
NucliSENS® easyMag® (bioMérieux, Durham, NC). 
Samples of total semen and seminal plasma were then re-
extracted using Qiagen® QIAamp Viral RNA mini kit 250 
(QIAGEN, Hilden, Germany) according to manufacturer’s 
recommendation. All RT-PCRs were performed with 10 µL 
of RNA samples by using the Taqman Fast virus OneStep 
Kit (Applied Biosystems, Forest City, CA) as previously 
described13 and following the manufacturer’s protocol.
Spermograms were all read fresh at the Araraquara clinic 
by a single experienced fertility clinic technician who was 
not blinded to the ZIKV status of the patients. 
FSH and LH hormonal levels were measured using 
electrochemiluminometric assays, while testosterone 
and inhibin B were measured using serum samples 
chemiluminescence assays. 
For comparison, spermogram results were compared 
with normal parameters from the World Health Organization 
(WHO)14 and with parameters obtained from a consecutive 
sample of men without history of ZIKV symptoms and 
without past history of infertility who collected semen 
samples in the same region (State) and period.
All participants signed informed consent forms upon 
participation. The study was approved by the Ethics 
Review Board at University of Sao Paulo Medical School 
(committee’s reference Nº 2.554.861).
RESULTS 
Between January and September 2016, 238 suspected 
ZIKV notifications were reported at Araraquara referent 
healthcare unit. Clinical definition of notified cases 
included patients presenting with maculopapular rash 
along with at least two of the following symptoms: fever, 
conjunctivitis, arthritis or periarticular edema. Of these 
patients, 187 were tested by RT-PCR and 101 (29 men) had 
positive ZIKV RT-PCR in plasma and/or urine samples. 
Adult male patients with confirmed ZIKV infections 
were invited to respond to a retrospective questionnaire 
of genital symptoms and to provide a semen sample for 
RT-PCR testing and spermogram analysis. Of 15 adult male 
participants for whom telephone contact was successful, 14 
responded to the questionnaire of genital symptoms and 
six consented to provide a semen sample at a median of 
12 months after the acute infection (range 11-12 months; 
Figure 1). All semen samples were delivered < 3 h after 
production. In the questionnaire of genital symptoms, two 
participants reported burning sensation when urinating at 
the time of acute ZIKV infection and one reported visible 
blood in urine; testicular pain or other abnormalities were 
not described and all participants were asymptomatic at the 
time the questionnaire was applied.
Figure 1 - Selection of study participants.
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ZIKV RT-PCR was negative in semen samples for 
all six participants. Spermogram analysis was performed 
for five participants, revealing abnormalities in seminal 
parameters in four of them, compared to WHO standards 
and local healthy men values. Although only one participant 
had sperm concentration below the lower reference 
limit (LRL) of 15 x 106/mL, two other participants 
had concentration near the LRL (17 and 26 x 106/mL). 
Progressive motility analysis was performed for three 
participants who delivered the semen sample less than 
2 h after production; abnormal motility was seen in all 
three cases (2.5%, 14% and 22% progressive motility, 
respectively compared to expected LRL of 32%). 
Table 1 shows results for each ZIKV-infected participant, 
contrasted with LRL from WHO14 and with median 
parameters of 17 local, healthy men without history 
of ZIKV symptoms or infertility antecedents. Of note, 
this comparison group was younger than ZIKV-infected 
patients included in the study. No ZIKV testing was 
performed in plasma, urine or semen specimens of 
this comparison group. Hormonal testing revealed no 
anomalies; values of testosterone (in patient 6) and 
inhibin B (in patient 1) were low, although still within 
the reference values. 
ZIKV-infected participants with abnormal spermogram 
results were referred for a free a consultation with a fertility 
specialist, but results from this evaluation were not available 
at the time of reporting. 
DISCUSSION AND CONCLUSIONS
Despite methodological limitations, restricted number 
of cases and incomplete semen analysis for two cases, 
our findings suggest a possible detrimental effect of 
ZIKV infection on human male fertility detectable at 
approximately 12 months after the acute ZIKV infection. 
Since spermatogenesis process in humans takes less than 
three months, our results indicate a possible persistent 
impairment in male fertility following symptomatic ZIKV 
infection. However, the normality of hormonal profiles 
of these men may be reassuring. This association should 
be further explored in well-characterized samples from 
cohort studies conducted in ZIKV-endemic areas including 
both symptomatic and asymptomatic men. Our results in 
an extension of a cohort study of 15 ZIKV-infected men 
followed up in Guadeloupe over six months, who showed a 
temporary effect of ZIKV on spermatogenesis and hormonal 
profiles, correlated with persistence of ZIKV shedding in 
the semen12. Since approximately half a million Brazilian 
men may have been infected with ZIKV during the 2015-16 
epidemic15,16, the long-term fertility sequelae may only 
appear now. ZIKV should be part of the investigations for 
men presenting to clinical services with fertility problems. 
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Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6
Asympto matic 
individuals* 
(N=17)
Reference 
values **
Age (years) 61 70 44 38 49 66 33 (30-35)
Months after ZIKV 
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